Drug delivery with carbon nanotubes for in vivo cancer treatment

被引:1025
作者
Liu, Zhuang [1 ]
Chen, Kai [2 ]
Davis, Corrine [3 ]
Sherlock, Sarah [1 ]
Cao, Qizhen [2 ]
Chen, Xiaoyuan [2 ]
Dai, Hongjie [1 ]
机构
[1] Stanford Univ, Dept Chem, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Mol Imaging Program Stanford, Dept Radiol,Biophys & BioX Program, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA
关键词
D O I
10.1158/0008-5472.CAN-08-1468
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chemically functionalized single-walled carbon nanotubes (SWNT) have shown promise in tumor-targeted accumulation in mice and exhibit biocompatibility, excretion, and little toxicity. Here, we show in vivo SWNT drug delivery for tumor suppression in mice. We conjugate paclitaxel (PTX), a widely used cancer chemotherapy drug, to branched polyethylene glycol chains on SWNTs via a cleavable ester bond to obtain a water-soluble SWNT-PTX conjugate. SWNT-PTX affords higher efficacy in suppressing tumor growth than clinical Taxol in a murine 4T1 breast cancer model, owing to prolonged blood circulation and 10-fold higher tumor PTX uptake by SWNT delivery likely through enhanced permeability and retention. Drug molecules carried into the reticuloendothelial. path-system are released from SWNTs and excreted via biliary way without causing obvious toxic effects to normal organs. Thus, nanotube drug delivery, is promising for high treatment efficacy and minimum side effects for future cancer therapy with low drug doses.
引用
收藏
页码:6652 / 6660
页数:9
相关论文
共 48 条
[1]   LIPOSOMES WITH PROLONGED CIRCULATION TIMES - FACTORS AFFECTING UPTAKE BY RETICULOENDOTHELIAL AND OTHER TISSUES [J].
ALLEN, TM ;
HANSEN, C ;
RUTLEDGE, J .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 981 (01) :27-35
[2]  
ARBUCK SG, 1993, MONOGR NCI, V15, P117
[3]   Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging [J].
Bartlett, Derek W. ;
Su, Helen ;
Hildebrandt, Isabel J. ;
Weber, Wolfgang A. ;
Davis, Mark E. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (39) :15549-15554
[5]   Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery [J].
Chen, XY ;
Plasencia, C ;
Hou, YP ;
Neamati, N .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (04) :1098-1106
[6]   Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescence [J].
Cherukuri, Paul ;
Gannon, Christopher J. ;
Leeuw, Tonya K. ;
Schmidt, Howard K. ;
Smalley, Richard E. ;
Curley, Steven A. ;
Weisman, R. Bruce .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (50) :18882-18886
[7]   Renal clearance of quantum dots [J].
Choi, Hak Soo ;
Liu, Wenhao ;
Misra, Preeti ;
Tanaka, Eiichi ;
Zimmer, John P. ;
Ipe, Binil Itty ;
Bawendi, Moungi G. ;
Frangioni, John V. .
NATURE BIOTECHNOLOGY, 2007, 25 (10) :1165-1170
[8]   SYNTHESIS OF CONGENERS AND PRODRUGS .3. WATER-SOLUBLE PRODRUGS OF TAXOL WITH POTENT ANTITUMOR-ACTIVITY [J].
DEUTSCH, HM ;
GLINSKI, JA ;
HERNANDEZ, M ;
HAUGWITZ, RD ;
NARAYANAN, VL ;
SUFFNESS, M ;
ZALKOW, LH .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (04) :788-792
[9]  
EISEMAN JL, 1994, CANCER CHEMOTH PHARM, V34, P465, DOI 10.1007/BF00685656
[10]   Inhibition of etoposide elimination in the isolated perfused rat liver by Cremophor EL and Tween 80 [J].
Ellis, AG ;
Crinis, NA ;
Webster, LK .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 38 (01) :81-87